Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma US...

FDA Drug Recall #D-0736-2022 — Class II — March 17, 2022

Recall Summary

Recall Number D-0736-2022
Classification Class II — Moderate risk
Date Initiated March 17, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Aurolife Pharma, LLC
Location Dayton, NJ
Product Type Drugs
Quantity 4080 bottles

Product Description

Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, NDC 13107-014-01.

Reason for Recall

Presence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room.

Distribution Pattern

Nationwide in the USA and Puerto Rico

Lot / Code Information

Lot: 01421008A1, Exp 03/2023

Other Recalls from Aurolife Pharma, LLC

Recall # Classification Product Date
D-0877-2023 Class III Glycopyrrolate Tablets, USP, 1 mg, 100-count bo... May 18, 2023
D-0087-2023 Class II Glycopyrrolate Tablets, USP, 1 mg, 100 tablets,... Dec 16, 2022
D-1869-2019 Class II Allergy Relief (Fexofenadine HCl) tablets USP, ... Aug 23, 2019
D-1868-2019 Class II Fexofenadine Hydrochloride Tablets USP, 180 mg,... Aug 23, 2019
D-1864-2019 Class II Fexofenadine Hydrochrloride Tablets USP, 180 mg... Aug 23, 2019

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.